جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

55 مُخرَج نتائج البحث عن «Type 2 diabetes»

مراجعةوصول مفتوح20262استشهاد· Semantic Scholar

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-Analysis

Cureus · مجلد 18 (2) · e103029-e103029

Type 2 diabetes mellitus (T2DM) increases the risk of cardiovascular morbidity and end-stage renal disease. Renin-angiotensin-aldosterone system (RAAS) inhibitors, specifically angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are standard therapies for organ protection. However, uncertainty remains regarding their comparative efficacy and the safety of combination therapy. This systematic review and meta-analysis aimed to compare the efficacy of ACEIs versus ARBs in reducing cardiovascular and renal events in patients with T2DM and to assess the safety of dual blockade. PubMed, EMBASE, and Cochrane databases were searched for randomized controlled trials (RCTs) published up to 2025 comparing ACEIs, ARBs, or their combination against placebo or active controls in T2DM patients. The primary outcome was a composite of cardiovascular death, myocardial infarction, stroke, and renal failure. Methodological quality was assessed using the Cochrane Risk of Bias 2 tool. Data were synthesized using frequentist pairwise and Bayesian network meta-analyses. Heterogeneity was explored via meta-regression, and trial sequential analysis (TSA) was used to assess the sufficiency of evidence. In total, 16 RCTs involving 47,406 participants were included. In pairwise analysis, both ACEIs (risk ratio (RR) = 0.87, 95% confidence interval (CI) = 0.81-0.94) and ARBs (RR = 0.90, 95% CI = 0.83-0.98) significantly reduced the risk of the primary composite endpoint compared to control. Network meta-analysis showed no statistically significant difference between ACEIs and ARBs (RR = 0.98, 95% CI = 0.88-1.09). Although ACEIs ranked slightly higher in probability for reducing all-cause mortality (surface under the cumulative ranking = 78% vs. 65%), this difference was not statistically significant. Dual blockade (ACEI + ARB) increased the risk of hyperkalemia (RR = 2.8) and acute kidney injury (RR = 1.7) without improving efficacy. Meta-regression identified baseline systolic blood pressure as a significant modifier of treatment benefit (p = 0.04). TSA indicated that the evidence for the RAAS blockade's benefit is conclusive. ACEIs and ARBs exhibit comparable efficacy in preventing cardiovascular and renal events in patients with T2DM, with a marginal mortality benefit favoring ACEIs. Dual blockade is associated with increased harm and is not recommended. Monotherapy with either agent remains the preferred strategy for organ protection.

ACE inhibitorsangiotensin receptor blockerstype 2 diabetesrenin-angiotensin-aldosterone system blockade
مقالوصول مفتوح20261استشهاد· Semantic Scholar

The Impact of Ramadan Fasting on Glycemic and Blood Pressure Control in a Large Saudi Arabian Cohort with Type 2 Diabetes and Hypertension: A Longitudinal Interrupted Time Series Analysis

Health Services Insights · مجلد 19 · 11786329261450733-11786329261450733

Introduction: The yearly observance of Ramadan, which includes prolonged daily fasting, presents a challenging scenario for patients with chronic illnesses, with existing studies presenting inconsistent findings on its metabolic implications. Objective: This study aimed to objectively measure the immediate and sustained impacts of Ramadan fasting on monthly mean Hemoglobin A1c (HbA1c), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) in a large, real-world cohort of Saudi Arabian patients with concomitant T2DM and HTN. Methods: A retrospective longitudinal study was carried out using electronic health record (EHR) data from a Saudi multi-facility healthcare system from December 2023 to May 2024. The analysis used a segmented regression for Interrupted Time Series (ITS) to estimate changes in outcomes, with Ramadan (March 2024) serving as the intervention point. Results: = .002), indicating a rebound impact. The reduction in SBP was not sustained, as it returned to pre-Ramadan levels in the months that followed. Conclusions: In this large Saudi cohort, Ramadan fasting was linked to transitory improvements in glycemic and blood pressure control. The ensuing rebound implies that, while fasting can be metabolically advantageous, the effects do not last without ongoing intervention. These results highlight the important necessity for rigorous post-Ramadan clinical follow-up to consolidate any gains made during the fasting period. These findings position Ramadan as a novel window for metabolic reset and a potential preventive opportunity against cardiorenal metabolic syndrome progression in high-risk populations.

Ramadan fastingtype 2 diabeteshypertensionglycemic control
مقالوصول مفتوح2026

Medication Adherence Among Adults with Diabetes in Jazan, Saudi Arabia: Role of Pharmacist Support and Digital Health

Patient Preference and Adherence · مجلد Volume 20 · 1-21

Background: Medication adherence is critical for achieving optimal glycemic control and preventing diabetes-related complications. However, poor adherence remains a major barrier to effective diabetes management worldwide. Evidence regarding factors associated with medication adherence among adults with diabetes in Saudi Arabia remains limited. This study aimed to assess medication adherence among adults with diabetes and examine associations of sociodemographic, clinical, pharmacist-related, and digital health factors with adherence levels. Methods: A cross-sectional study was conducted among adults with type 1 or type 2 diabetes attending a specialized diabetes center in Jazan, Saudi Arabia, during February-March 2025. Participants were recruited using non-probability convenience sampling. Of 489 patients approached, 388 completed the questionnaire, yielding a response rate of 79.3%. Data were collected using a bilingual (Arabic/English) electronic questionnaire. Medication adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Descriptive statistics, bivariate analyses, correlation analysis, and multinomial logistic regression were performed using IBM SPSS Statistics version 27. Results: Overall, 77.1% of participants demonstrated low medication adherence, while 16.5% and 6.4% demonstrated moderate and high adherence, respectively. In the adjusted multinomial logistic regression model, higher satisfaction with the current diabetes management plan was significantly associated with greater odds of moderate adherence (OR=1.650, 95% CI: 1.212-2.245, P=0.001) and high adherence (OR=2.038, 95% CI: 1.165-3.565, P=0.013) compared with low adherence. Insulin use was associated with moderate vs low adherence (OR=2.175, 95% CI: 1.008-4.692, P=0.048), but not with high adherence. Participants who did not use mobile applications or digital health tools had higher odds of high vs low adherence than those who used such tools (OR=2.685, 95% CI: 1.007-7.154, P=0.048). Age and comorbid conditions were not significantly associated with adherence level in the adjusted model. Frequency of pharmacist consultation was significant overall (P=0.001), although individual category comparisons did not demonstrate a consistent pattern across adherence levels. Multicollinearity diagnostics indicated no problematic collinearity (VIF=1.04-1.34; tolerance ≥0.75). Conclusion: Medication adherence was predominantly low among study participants. Higher satisfaction with diabetes management was consistently associated with greater adherence, while insulin use and digital health tool use showed category-specific associations. The unexpected association between digital-tool non-use and high adherence should be interpreted cautiously and does not establish a causal effect of digital technology on adherence. Further longitudinal and prospective studies are warranted to clarify these associations and determine how structured pharmacist engagement and personalized digital-health strategies can be optimally incorporated into patient-centered diabetes care.

medication adherencediabetes mellitustype 1 diabetestype 2 diabetes
مقالوصول مفتوح2026

Perceived Stress, Sleep Quality, and Their Impact on Glycemic Control among Type 2 Diabetes Patients in Riyadh: Cross-Sectional Evidence

Medical Principles and Practice · 1-1

OBJECTIVE: The aim of this study was to investigate the relationship between perceived stress and sleep quality with glycemic blood levels in T2DM patients in Riyadh. SUBJECT AND METHODS: This cross-sectional study evaluated a total of 309 patients diagnosed with type 2 diabetes mellitus in Riyadh, Saudi Arabia. The study comprised an initial validation and Arabic translation phase involving 160 participants, followed by an analytical phase focusing on 149 adult patients. To investigate the impact of psychosocial and metabolic factors on glycemic control (hemoglobin A1c [HbA1c]), data were collected using the Pittsburgh Sleep Quality Index (PSQI) and the Perceived Stress Scale (PSS-10), alongside clinical metrics such as body mass index (BMI) and dyslipidemia extracted from medical records. A multivariable linear regression model was utilized to identify independent factors associated with glycemic regulation within the local population. RESULTS: The multivariable regression model demonstrated robust explanatory power (adjusted R2 = 0.726, p < 0.001). Traditional risk factors, specifically elevated BMI (β = 0.448, p < 0.001) and dyslipidemia (β = 0.304, p < 0.001), were significantly associated with higher HbA1c levels. Notably, poor sleep quality emerged as a significant independent factor associated with elevated HbA1c (β = 0.261, p < 0.001), whereas perceived stress did not exhibit a significant correlation. Conversely, physical activity demonstrated a significant protective effect, correlating with lower HbA1c (β = -0.271, p < 0.001). CONCLUSION: Poor sleep quality, rather than perceived psychological stress, is a primary factor independently associated with hyperglycemia in this patient cohort. These findings suggest that standard diabetes care should integrate formal sleep assessments alongside patient care management.

type 2 diabetesperceived stresssleep qualityglycemic control
مراجعةوصول مفتوح202519استشهاد· Semantic Scholar

Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review

Cureus · مجلد 17 (9) · e92454-e92454

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have recently gained widespread use among patients with type 2 diabetes mellitus or obesity, owing to their substantial impact in lowering blood glucose levels and reducing body weight. Apart from this, the FDA Adverse Event Reporting System (FAERS) identified several dermatological side effects, including hair loss, associated with the administration of GLP-1 RAs, prompting further research. This systematic review aimed to provide a comprehensive and up-to-date overview of hair loss related to the use of GLP-1 RAs. The search strategy utilized PubMed, SCOPUS, and Web of Science databases using key terms: (("GLP-1 receptor agonist"[Mesh] OR "GLP1- receptor agonist"[tiab] OR "Glucagon-Like Peptide 1"[tiab] OR "GLP-1 agonist"[tiab] OR semaglutide[tiab] OR liraglutide[tiab] OR tirzepatide[tiab] OR exenatide[tiab] OR dulaglutide[tiab]) AND (hair loss[Mesh] OR alopecia[tiab] OR "telogen effluvium"[tiab] OR "alopecia areata"[tiab] OR hair[tiab]) ). Including all primary English studies, the hair loss outcomes associated with the use of GLP-1 RA in adults were reported without time restriction. A total of five relevant studies were included in this review, encompassing 2,905 adult patients who received subcutaneous trizepatide mainly on a weekly basis. The study yielded conflicting findings, with some indicating significant improvement and hair regrowth, while others reported hair loss as an adverse dermatological event. Further research is recommended to clarify the relationship between GLP-1 RAs and alopecia.

GLP-1 receptor agonistshair losstelogen effluviumalopecia areata
مقالوصول مفتوح20259استشهاد· Semantic Scholar

Prevalence and impact of sociodemographic factors, comorbidities, and lifestyle on diabetes complications among patients with type 2 diabetes in Riyadh

Scientific Reports · مجلد 15 (1) · 17299-17299

Diabetes mellitus (DM) is a growing public health concern globally, particularly in Saudi Arabia, where increasing prevalence is associated with significant morbidity. This study aimed to assess the prevalence of diabetes-related complications among patients in Riyadh and examine the impact of sociodemographic factors, comorbidities, and lifestyle habits on these complications. A cross-sectional study was conducted with 980 diabetic patients attending health centers in Riyadh from March to April 2023. Data were collected via a validated bilingual questionnaire that captured sociodemographic information, diabetes-related variables, comorbid conditions, lifestyle habits, and complications. Statistical analyses, including descriptive statistics, chi-square tests, and binary regression, were performed via SPSS to identify significant associations. A p-value less than 0.05 was considered significant for all comparisons. Among the participants (980), 38% (378) reported diabetes-related complications, primarily neuropathy (30%), retinopathy (25%), and cardiovascular diseases (20%). Complications were significantly associated with older age (p < 0.001) and longer diabetes duration (more than 5 years; p < 0.001). Individuals with hypertension, hyperlipidemia, heart disease, kidney disease, and obesity had significantly higher complication rates than those without these conditions (p < 0.05). The most pronounced association was observed in participants with heart disease (85% vs. 15%; RR = 1.506), highlighting the need for better management of these comorbidities. Consuming fruits and vegetables, milk, and regular exercise were inversely associated with the risk of complications (p < 0.05). Conversely, sugary drinks, white bread, sheesha/vaping, and inadequate sleep were linked to increased risk (p < 0.05), highlighting the protective role of healthy dietary and lifestyle habits. This study highlights the impact of sociodemographic factors and lifestyle choices-such as age, education, family history, comorbidities, and poor diet-on diabetes complications. While early detection and lifestyle interventions are vital, a cautious approach is needed when applying these findings to other regions, given differences in socioeconomic circumstances.

type 2 diabetesdiabetes complicationsdiabetic neuropathydiabetic retinopathy
مراجعةوصول مفتوح20254استشهاد· Semantic Scholar

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Trials

Cureus · مجلد 17 (6) · e86232-e86232

Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity in individuals with type 2 diabetes mellitus (T2DM), contributing to increased liver-related complications and cardiovascular risk. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as potential treatments offering benefits for both metabolic and liver-related outcomes. This systematic review evaluated the efficacy of SGLT2 inhibitors in improving hepatic steatosis, liver enzymes, glycemic control, and liver histology in patients with T2DM and NAFLD. The review was conducted using a structured methodology, including systematic database searches and risk of bias assessments. Included randomized controlled trials (RCTs) investigated various SGLT2 inhibitors, such as dapagliflozin, empagliflozin, ertugliflozin, and ipragliflozin. Most studies showed significant reductions in liver fat content, improvements in serum liver enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT)), and favorable effects on blood pressure, triglycerides, and body composition. Glycemic control markers, including glycated hemoglobin (HbA1c), fasting glucose, and insulin resistance indices, also improved. One biopsy-based study demonstrated histological improvements, including reduced fibrosis and resolution of nonalcoholic steatohepatitis (NASH). No serious adverse events were reported. These findings suggest SGLT2 inhibitors may offer dual benefits for managing both diabetes and fatty liver disease. Further long-term studies focusing on liver histology as a primary endpoint are needed to confirm these effects.

SGLT2 inhibitorstype 2 diabetesnon-alcoholic fatty liver diseasedapagliflozin
مقالوصول مفتوح20251استشهاد· Semantic Scholar

Massive Hemoptysis Secondary to Rasmussen’s Aneurysm in a Patient With Active Pulmonary Tuberculosis: A Case Report

Cureus · مجلد 17 (12) · e99117-e99117

Rasmussen's aneurysm is a rare but potentially deadly pseudoaneurysm of a pulmonary arterial branch adjacent to a tuberculous cavity. This report describes the case of a 38-year-old Bangladeshi man with uncontrolled type 2 diabetes who presented with sudden massive hemoptysis following six months of cough, weight loss, fever, and pleuritic chest pain. Imaging showed bilateral cavitary pulmonary tuberculosis with a pseudoaneurysm of the left lower-lobe pulmonary artery, consistent with a ruptured Rasmussen's aneurysm. Urgent endovascular embolization achieved complete hemostasis. This case exemplifies the paramount importance of timely recognition and prompt therapeutic intervention in reducing mortality arising from tuberculosis-associated pulmonary hemorrhage.

Rasmussen's aneurysmmassive hemoptysispulmonary tuberculosiscavitary tuberculosis
مقالوصول مفتوح20251استشهاد· Semantic Scholar

Prevalence and associated factors of peripheral neuropathy in individuals with type 2 diabetes mellitus: a cross-sectional study in Khartoum State

BMC Endocrine Disorders · مجلد 26 (1) · 8-8

BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common and costly complication that occurs in both Type 1 and Type 2 diabetes mellitus. The prevalence of neuropathy is estimated to be around 8% in newly diagnosed patients and exceeds 50% in those with long-standing disease. The aim of this study was to determine the prevalence of DPN among individuals with Type 2 diabetes mellitus in Sudan and to identify the factors associated with DPN. METHODOLOGY: This cross-sectional study was conducted in the outpatient setting of an endocrinology clinic at a tertiary care centre (Diabetes Specialized Centres) in Khartoum State between January 2020 and January 2021. RESULTS: Out of the 236 patients included in the study, the mean age was 55.7 ± 11.5 years, and 54.7% were female. The prevalence of DPN was found to be 43%. Logistic regression analysis revealed that the following factors were significantly associated with DPN: body mass index (BMI) (P = 0.022, OR = 3.733), male gender (P = 0.003, OR = 7.165), educational level (P = 0.034, OR = 20.577), duration of diabetes (P = 0.014, OR = 13.121), age (P = 0.001, OR = 2.735), HbA1c level (P = 0.002, OR = 1.782), alcohol consumption (P = 0.000, OR = 212.158), smoking status (P = 0.005, OR = 0.063), and the presence of hypertension (P = 0.001, OR = 11.493). CONCLUSION: There a relatively high prevalence of DPN in the diabetic population of Sudan, and significantly associated with the duration of diabetes, BMI, age, HbA1c levels, male gender, alcohol consumption, smoking status, and hypertension. Regular screening and patient education are needed to reduce DPN in Sudanese patients with diabetes. CLINICAL TRIAL NUMBER: NA.

diabetic peripheral neuropathytype 2 diabetesprevalencerisk factors
مقالمفتوح (مستودع)20251استشهاد· Semantic Scholar

Elucidating Microbiota-driven Vitamin B12 Malabsorption in Diabetic Neuropathy through Fecal Microbiota Transplantation and Multiomics Profiling in Germ-free Mice

Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 523-528

Background: Diabetic neuropathy is a common and disabling complication of type 2 diabetes (T2D), often linked to Vitamin B12 deficiency. Despite observed B12 malabsorption in T2D patients, the role of gut microbiota in this process is poorly understood. Methods: We established a novel fecal microbiota transplantation (FMT) model using samples from T2D patients stratified by B12 status and neuropathy severity, transplanted into germ-free mice. We assessed ileal expression of B12 transporters, serum B12 levels and cobalamin-related metabolites. Neuropathy progression was evaluated through nerve conduction studies and histopathological analysis. Microbial composition was analysed through 16S rRNA sequencing, and metabolomic data were obtained using ion mobility-enhanced liquid chromatography-mass spectrometry. Machine learning algorithms integrated microbial and host data to identify predictive patterns and therapeutic targets. Results: FMT from T2D donors with B12 deficiency led to decreased expression of B12 absorption markers and reduced serum B12 levels in recipient mice. These mice showed early signs of neuropathy, confirmed by slowed nerve conduction and structural nerve damage. Specific microbial taxa were significantly associated with altered B12 metabolism and indicators of neuropathy. Multiomics and machine learning analyses revealed key microbial signatures and metabolic pathways involved in B12 dysregulation. Conclusion: Gut microbiota plays a mechanistic role in Vitamin B12 malabsorption and the progression of diabetic neuropathy. This model provides a platform for microbiota-informed diagnostics and targeted interventions in T2D complications.

diabetic neuropathyvitamin B12 malabsorptiongut microbiotatype 2 diabetes
مقالوصول مفتوح2025

Knowledge, Attitudes, and Practices Toward Weight Management Among Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Cross-Sectional Study

Healthcare · مجلد 13 (21) · 2770-2770

Background/Objectives: Weight management is crucial for preventing and managing diabetes. This study aimed to evaluate the knowledge, attitude, and practice (KAP) of people with Type 2 Diabetes Mellitus (T2DM) regarding weight management in Saudi Arabia. Methods: This cross-sectional survey of patients with T2DM in Saudi Arabia was conducted from October 2024 to February 2025. Participants completed a self-administered online questionnaire, which was validated and adapted from a previous study. Results: Among 385 individuals, 60.0% were females, and 34.0% were between 18 and 25 years old. The average scores for knowledge, attitude, and practice were 8.7 ± 3.6 (possible range: 0–13), 28.5 ± 4.4 (possible range: 10–50), and 28.3 ± 4.0 (possible range: 9–45), respectively. Pearson’s correlation analysis shows no significant correlation between knowledge and attitude (r = −0.016, p = 0.750). However, a weak yet statistically significant positive correlation was found between knowledge and practice (r = 0.155, p = 0.002). Additionally, a moderate negative correlation was observed between attitude and practice (r = −0.353, p = 0.001). Conclusions: The participants exhibited moderate knowledge, negative attitudes, and moderate practices regarding weight management. These findings provide crucial guidance for developing healthcare strategies to improve the KAP of diabetic patients in weight management.

type 2 diabetesweight managementknowledge, attitudes and practicesobesity
مقالوصول مغلق2025

Impact of Neutrophil Extracellular Trapping on Hypervirulent Klebsiella pneumoniae in Type 2 Diabetes Mellitus

The Egyptian Journal of Medical Microbiology · مجلد 34 (2) · 189-194

Background: There is increasing evidence that type 2 diabetes mellitus (T2D) patient has higher risk for hypervirulent Klebsiella pneumoniae (hvKP) infections. Neutrophils achieve different immunological functions such as phagocytosis, and neutrophil extracellular trap (NETs) formation to arrest and eradicate microbes such as hvKp. Physicians have restricted curative approach for treatment of infection due to these superbugs. This necessitates to more understand innate immune arm included in these infections. Objective: This study aimed to investigate in vitro interaction of human NETs (as one of innate immune components) with hvKp in T2D. Methodology: Twenty patients with T2D and twenty age and sex matched healthy persons as healthy controls (HCs) were included in this study. By using clinical-derived hvKp strains, NETs complex testing by immunofluorescence, phagocytosis detection and NETs killing analysis were performed. Results: Direct killing of diabetic patients NETs against hvKp strain significantly decreased compared to NETs of HCs despite NETosis induction was significantly higher in neutrophils of T2D patients, compared to neutrophils of HCs. HvKp showed significantly lower level of phagocytosis compared to the control strain (14.65% vs. 96.43%). However, insignificant difference in the level of phagocytosis was detected between T2D and HCs neutrophils. Conclusion: Our study suggests that impaired NETs bactericidal ability makes diabetic patient more susceptible to develop hvKp invasive infection. This will shed light on a novel NETs dependant therapeutic approach and improved therapeutic plan against hvKP infection in T2D patient.

neutrophil extracellular trapshypervirulent Klebsiella pneumoniaetype 2 diabetesNETosis
مقالوصول مفتوح202435استشهاد· Semantic Scholar

Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathy

International Journal of Pharmaceutics X · مجلد 7 · 100232-100232

Diabetes mellitus (DM) is the most prevalent cause of diabetic retinopathy (DRP). DRP has been recognized for a long time as a microvascular disease. Many drugs were used to treat DRP, including vildagliptin (VLD). In addition to its hypoglycemic effect, VLD minimizes ocular inflammation and improves retinal blood flow for individuals with type 2 diabetes mellitus. Nevertheless, VLD can cause upper respiratory tract infections, diarrhea, nausea, hypoglycemia, and poor tolerability when taken orally regularly due to its high water solubility and permeability. Effective ocular administration of VLD is achieved using solid lipid nanoparticles (SLNPs), which improve corneal absorption, prolonged retention, and extended drug release. Ocuserts (OCUs) are sterile, long-acting ocular dosage forms that diminish the need for frequent dosing while improving residence time and stability. Therefore, this study intends to develop VLD solid lipid nanoparticle OCUs (VLD-SLNPs-OCUs) to circumvent the issues commonly associated with VLD. SLNPs were prepared using the double-emulsion/melt dispersion technique. The optimal formula has been implemented in OCUs. Optimization and development of VLD-SLNPs-OCUs were performed using a Box-Behnken Design (BBD). VLD-SLNPs-OCUs loading efficiency was 95.28 ± 2.87%, and differential scanning calorimetry data (DSC) showed the full transformation of VLD to an amorphous state and the excellent distribution in the prepared OCUs matrices. The in vivo release of VLD from the optimized OCUs after 24 h was 35.12 ± 2.47%, consistent with in vitro drug release data of 36.89 ± 3.11. The optimized OCUs are safe to use in the eye, as shown by the ocular irritation test. VLD-SLNPs-OCUs provide extended VLD release, an advantageous alternative to conventional oral dose forms, resulting in fewer systemic adverse effects and less variation in plasma drug levels. VLD-SLNPs-OCUs might benefit retinal microvascular blood flow beyond blood glucose control and may be considered a promising approach to treating diabetic retinopathy.

vildagliptinsolid lipid nanoparticlesOcusertocular drug delivery
مقالوصول مفتوح202416استشهاد· Semantic Scholar

Antidiabetic and antioxidant potential of Crocin in high-fat diet plus streptozotocin-induced type-2 diabetic rats

International Journal of Immunopathology and Pharmacology · مجلد 38 · 3946320231220178-3946320231220178

OBJECTIVES: Crocin, the principal water-soluble active constituent of saffron, possesses numerous pharmacological activities. The present investigation examined the potential antidiabetic and antioxidant characteristics of Crocin in rats with type-2 diabetes by administering it orally and intraperitoneally (i.p.). METHODS: After 2 weeks of a high-fat diet, streptozotocin (STZ) (i.p., 40 mg/kg) was administered to male adult rats to induce type-2 diabetes mellitus. Body weight and fasting blood glucose (FBG) were measured on days zero, weeks 1, and 2. At the end of 2 weeks of drug administration in their respective groups, fasting insulin and glucose levels were estimated, and insulin resistance (HOMA-IR) was determined. Intraperitoneal glucose (IPGTT) and insulin tolerance tests (ITT) were carried out. Histopathological investigation and biochemical parameters were estimated in pancreatic tissues. RESULTS: The Crocin (100 mg/kg) treatment has significantly improved body weight, abatement of FBG, fasting insulin, and HOMA-IR. Likewise, Crocin treatment significantly improved the glucose and insulin challenges. We observed a significantly marked elevation in endogenous antioxidant enzymes in Crocin-treated groups. Similarly, Crocin treatment reversed the histopathological changes and restored the normal integrity and function of the pancreas. CONCLUSION: The overall finding indicates that intraperitoneal administration of Crocin demonstrated better control of glycemic level and body weight. Further, it has improved insulin levels in the serum and potentiated antioxidant properties.

crocinsaffrontype 2 diabetesantidiabetic activity
مقالوصول مفتوح202413استشهاد· Semantic Scholar

Pilot-Study to Explore Metabolic Signature of Type 2 Diabetes: A Pipeline of Tree-Based Machine Learning and Bioinformatics Techniques for Biomarkers Discovery

Nutrients · مجلد 16 (10) · 1537-1537

BACKGROUND: This study aims to identify unique metabolomics biomarkers associated with Type 2 Diabetes (T2D) and develop an accurate diagnostics model using tree-based machine learning (ML) algorithms integrated with bioinformatics techniques. METHODS: Univariate and multivariate analyses such as fold change, a receiver operating characteristic curve (ROC), and Partial Least-Squares Discriminant Analysis (PLS-DA) were used to identify biomarker metabolites that showed significant concentration in T2D patients. Three tree-based algorithms [eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), and Adaptive Boosting (AdaBoost)] that demonstrated robustness in high-dimensional data analysis were used to create a diagnostic model for T2D. RESULTS: As a result of the biomarker discovery process validated with three different approaches, Pyruvate, D-Rhamnose, AMP, pipecolate, Tetradecenoic acid, Tetradecanoic acid, Dodecanediothioic acid, Prostaglandin E3/D3 (isobars), ADP and Hexadecenoic acid were determined as potential biomarkers for T2D. Our results showed that the XGBoost model [accuracy = 0.831, F1-score = 0.845, sensitivity = 0.882, specificity = 0.774, positive predictive value (PPV) = 0.811, negative-PV (NPV) = 0.857 and Area under the ROC curve (AUC) = 0.887] had the slight highest performance measures. CONCLUSIONS: ML integrated with bioinformatics techniques offers accurate and positive T2D candidate biomarker discovery. The XGBoost model can successfully distinguish T2D based on metabolites.

type 2 diabetesmetabolomics biomarkersmetabolic signaturesXGBoost